<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03821129</url>
  </required_header>
  <id_info>
    <org_study_id>GSO 18-01</org_study_id>
    <nct_id>NCT03821129</nct_id>
  </id_info>
  <brief_title>GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study</brief_title>
  <acronym>REDUCE PAS</acronym>
  <official_title>GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a
      post approval setting and evaluate the quality of operator education and training and
      transferability of trial experience to a post-market setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A maximum of 636 adult subjects will be enrolled at up to 40 U.S. centers. Subjects will have
      follow-up at 1 month, 6 months, 12 months and annually thereafter through 5 years post
      implant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 25, 2019</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of subjects with recurrent ischemic stroke post study device implant (Primary Effectiveness Outcome)</measure>
    <time_frame>24 months</time_frame>
    <description>Proportion of subjects with recurrent ischemic stroke post study device implant</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of subjects with device- or procedure-related serious adverse events at 30 days (Primary Safety Endpoint)</measure>
    <time_frame>30 days</time_frame>
    <description>Device- or procedure- related serious adverse events post study device implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effective PFO Closure defined as complete PFO closure or a trivial or small residual shunt by Echocardiographic assessment</measure>
    <time_frame>12 months</time_frame>
    <description>Complete PFO closure or a trivial or small residual shunt
Proportion of subjects with complete PFO closure or a trivial or small residual shunt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically Significant New Atrial Arrhythmia</measure>
    <time_frame>60 months</time_frame>
    <description>Any new atrial fibrillation or flutter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically Significant New Atrial Arrhythmia by Age</measure>
    <time_frame>60 months</time_frame>
    <description>Any new atrial fibrillation or flutter in patients greater and less than 60 years of age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual Shunt Characterization via assessment of shunt in patients by Echo</measure>
    <time_frame>24 months</time_frame>
    <description>Assessment of shunt in patients by Echo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical Success defined as successful delivery and retention of the GSO device based on physician reporting</measure>
    <time_frame>Index procedure</time_frame>
    <description>Successful delivery and retention of the GSO device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success defined as successful implantation of the GSO device with no reported in-hospital Serious Adverse Events (SAEs)</measure>
    <time_frame>Enrollment through discharge, approximately 1 day</time_frame>
    <description>Successful implantation of the GSO device with no reported in-hospital SAEs</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">636</enrollment>
  <condition>Stroke</condition>
  <condition>PFO - Patent Foramen Ovale</condition>
  <arm_group>
    <arm_group_label>GORE® CARDIOFORM Septal Occluder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single Arm Commercially available GORE® CARDIOFORM Septal Occluder</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PFO closure with GORE® CARDIOFORM Septal Occluder</intervention_name>
    <description>PFO closure with GORE® CARDIOFORM Septal Occluder in patients with ischemic stroke</description>
    <arm_group_label>GORE® CARDIOFORM Septal Occluder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with an ischemic stroke presumed to be an embolic stroke of undetermined
             source (ESUS) verified by a neurologist within the last 365 days prior to enrollment.

          -  Presence of Patent Foramen Ovale (PFO), as determined initially by positive bubble
             study utilizing transesophageal echocardiography (TEE) and/or transcranial Doppler
             (TCD), demonstrating spontaneous right-to-left shunting or right-to-left shunting
             during Valsalva maneuver.

          -  Patient is able to tolerate antiplatelet therapy

          -  Note: Additional Inclusion Criteria may apply

        Exclusion Criteria:

          -  History of or ongoing atrial fibrillation/flutter

          -  Other co-morbidities including, but not limited to, mural thrombus, dilated
             cardiomyopathy, cardiac prosthetics (valves), severe native valve disease (including
             mitral valve stenosis), severe ventricular wall motion abnormalities, aortic
             dissection, significant atherosclerosis, vasculitis, pre-existing non-vascular
             neurologic disorders, pulmonary arteriovenous malformations, prior intracranial
             hemorrhage, severe disability related to prior stroke, autoimmune disorders that would
             increase the risk of stroke or thromboembolism, or associated with increased risk of
             infection or procedural complications, in the opinion of the investigator, left
             ventricular ejection fraction of &lt;40%, coexistent cause or intra-cardiac shunting
             (e.g. VSD or ASD)

          -  Previous Myocardial Infarction

          -  Rankin Scale sore greater than or equal to 3 at the time of procedure

          -  Active infection that cannot be treated successfully prior to enrollment

          -  Neurological deficits not due to stroke that may affect the patient's neurologic
             assessments

          -  Evidence of hypercoagulable state, Uncontrolled diabetes mellitus, uncontrolled
             systemic hypertension or pulmonary hypertension at the time of screening or procedure

          -  Sensitivity or contraindication to all proposed medical treatments or any device
             components

          -  Pregnant, lactating, or intent on becoming pregnant through 24 months after
             enrollment.

          -  Indications outside the parameters accepted for placement of GSO, including extensive
             congenital cardiac anomalies and defect diameters considered too large for closure
             with the device.

          -  Atrial septal anatomy that is expected to necessitate placement of more than one GORE®
             CARDIOFORM Septal Occluder

          -  Need for concomitant procedure(s) that may confound detection of adverse events
             related to device placement

          -  Note: Additional Exclusion Criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ignacio Inglessis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interventional Cardiology Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Volpi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Houston Methodist</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mickella Knapp</last_name>
    <phone>800-437-8181</phone>
    <email>GSO1801@wlgore.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Loma Linda University Health</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brent Gordon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rajendra Makkar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vaikom Mahadevan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Santa Barbara Cottage Hospital</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Aragon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Denver Cardiology Associates</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee MacDonald</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center of the Rockies</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Strote</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy Asnes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Cubeddu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chandanreddy Devireddy</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clifford Kavinsky</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Benzuly</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinic</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sidakpal Panaich</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catholic Health Initiatives- Iowa Corp dba Iowa Heart</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Tannenbaum</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Inglessis-Azuaje</last_name>
    </contact>
    <investigator>
      <last_name>Ignacio Inglessis-Azuaje</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanley Chetcuti</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Hanzel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Covenant Medical Center, Inc.</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Firas Alani</last_name>
    </contact>
    <investigator>
      <last_name>Firas Alani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gregory Helmer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation - Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Goessl</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Research Foundation SUNY Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vijay Iyer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center/NYPH</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Sommer</last_name>
    </contact>
    <investigator>
      <last_name>Robert Sommer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atrium Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph Paolillo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence Heart &amp; Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Jones</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Kluck</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Rhodes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tennova Healthcare</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malcolm Foster</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Piana</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine-Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guilherme Silva</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital - Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun Huie Lin</last_name>
    </contact>
    <investigator>
      <last_name>Chun Huie Lin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Healthcare Systems of San Antonio d/b/a Methodist Hospital</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Alvarez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intermountain Heart Institute</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Orford</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anwar Tandar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rohit Malhotra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sentara Cardiovascular Research Institute</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Mahoney</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zachary Steinberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Metro Inc.</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanvir Bajwa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin, Inc.</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Cinquegrani</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 15, 2019</study_first_submitted>
  <study_first_submitted_qc>January 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Occluder</keyword>
  <keyword>Patent Foramen Ovale</keyword>
  <keyword>PFO</keyword>
  <keyword>Stroke</keyword>
  <keyword>Gore Septal Occluder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Foramen Ovale, Patent</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

